SCOPUS 정보 검색 플랫폼

Volumn 19, Issue 4, 2001, Pages 273-281

Compatibility and stability of the investigational polypeptide marine anticancer agent kahalalide F in infusion devices

(7) Nuijen, Bastiaan a Bouma, Marjan a Manada, Consuelo b Jimeno, José M b Lazaro, Luis L b Bult, Auke c Beijnen, Jos H a,c

a SLOTERVAART HOSPITAL (Netherlands)

b PHARMAMAR S A (Spain)

c UTRECHT UNIVERSITY (Netherlands)

Author keywords

Cremophor EL; Infusion devices; Kahalalide F; Marine antitumor agent; Sorption; Stability

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; CREMOPHOR; KAHALALIDE F; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; POLYETHYLENE; POLYPEPTIDE; POLYVINYLCHLORIDE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL TRIAL; DRUG FORMULATION; DRUG PACKAGING; DRUG SELECTIVITY; DRUG STABILITY; DRUG STORAGE; HUMAN; INFUSION SYSTEM; LEACHING; MOLLUSC; PHASE 1 CLINICAL TRIAL; POWDER; PRIORITY JOURNAL; PROSTATE TUMOR;

ABSORPTION; ANIMALS; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; BIOCOMPATIBLE MATERIALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEPSIPEPTIDES; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; DRUG STABILITY; GLYCEROL; INFUSION PUMPS; INFUSIONS, INTRAVENOUS; MOLLUSK VENOMS; PEPTIDES; TIME FACTORS;

EID: 0034874668 PISSN: 01676997 EISSN: None Source Type: Journal
DOI: 10.1023/A:1010641207791 Document Type: Article

Times cited : (14)

References (11)

1
- 0030453986
- Progress in the acquisition of new marine-derived anticancer compounds: Development of ecteinascidin-743 (ET-743)
- (1996) Drugs of the Future , vol.21 , pp. 1155-1165
- Jimeno, J.M.¹ Faircloth, J.M.² Cameron, L.³ Meely, K.⁴ Vega, E.⁵ Gómez, A.⁶ Sousa-Faro, J.M.F.⁷ Rinehart, K.⁸

2
- 0001401063
- Preclinical pharmacology studies with the marine natural product kahalalide F
- (1999) Clin Cancer Res , vol.5
- Supko, J.G.¹ Lu, H.²

3
- 0000928357
- Preclinical development of kahalalide F, a new marine compound selected for clinical studies
- (2000) Proc Am Ass Cancer Res , vol.41 , pp. 600
- Faircloth, G.¹ Grant, W.² Smith, B.³ Supko, J.⁴ Brown, A.⁵ Geldof, A.⁶ Jimeno, J.⁷

4
- 0028034631
- Compatibility of paclitaxel injection vehicle with intravenous administration and extension sets
- (1994) Am J Hosp Pharm , vol.51 , pp. 2804-2810
- Trissel, L.A.¹ Xu, Q.² Kwan, J.³ Martinez, J.F.⁴

5
- 0033372151
- Compatibility and stability of aplidine, a novel marine-derived depsipeptide antitumor agent, in infusion devices, and its hemolytic and precipitation potential upon i.v. administration
- (1999) Anti-cancer Drugs , vol.10 , pp. 879-887
- Nuijen, B.¹ Bouma, M.² Henrar, R.E.C.³ Manada, C.⁴ Bult, A.⁵ Beijnen, J.H.⁶

6
- 0033010933
- Compatibility of paclitaxel in 5% glucose solution with ECOFLAC® low-density polyethylene containers - Stability under different storage conditions
- (1999) Int J Pharm , vol.178 , pp. 77-82
- Sautou-Miranda, V.¹ Brigas, F.² Vanheerswynghels, S.³ Chopineau, J.⁴

7
- 0032413585
- Compatibility and stability of bryostatin 1 in infusion devices
- (1999) Inv New Drugs , vol.16 , pp. 227-236
- Cheung, A.P.¹ Hallock, Y.F.² Vishnuvajjala, B.R.³ Nguyenle, T.⁴ Wang, E.⁵

8
- 0030861971
- Pharmaceutical properties of paclitaxel and their effects on preparation and administration
- (1997) Pharmacotherapy , vol.17
- Trissel, L.A.¹

9
- 0031052280
- Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials
- (1997) Am J Health-Syst Pharmac , vol.54 , pp. 566-569
- Mazzo, D.J.¹ Nguyen-Huu, J.J.² Pagniez, S.³ Denis, P.⁴

10
- 0029982715
- Plasticizer extraction of Taxol®-infusion solution from various infusion devices
- (1996) Pharmac World Sc , vol.18 , pp. 78-82
- Maas, B.¹ Huber, C.² Krämer, I.³

11
- 4243478062
- Report no. 710401001. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieuhygiene (RIVM)
- (1990) Exploratory report phthalates
- Sloof, W.¹ Janus, J.A.² Koning, C.J.M.³ Peijnenburg, W.J.G.M.⁴ Ros, J.P.M.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.